An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics

Cancer Chemotherapy and Pharmacology

Volumn 49, Issue 2, 2002, Pages 93-100

  Fujimoto, J ^a   Sakaguchi, H ^a   Aoki, I ^a   Khatun, S ^a   Tamaya, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Nude mouse; Ovary cancer; Therapeutics; Tumor progression

Indexed keywords

ALKALINE PHOSPHATASE; CARBOPLATIN; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPORTER GENE; TUMOR VOLUME;

ANIMALS; CARBOPLATIN; CELL DIVISION; FEMALE; HUMANS; ISOENZYMES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036161276     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-001-0396-0     Document Type: Article

References (21)

1. Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug eDcacy in ovarian cancer xenografts
2. Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice
3. Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells
4. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcriptase-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA
5. Weekly paclitaxel in the management of ovarian cancer
6. Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma
7. Chemotherapy for advanced ovarian cancer
8. Oxiplatin clinical activity: A review
9. Paclitaxel (Taxol)/carboplatin chemotherapy in the treatment of advanced ovarian cancer
10. Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis
11. Stromal-epithelial interactions in the progression of ovarian cancer: Influence and source of tumor stromal cells
12. Epidemiology and etiology of ovarian cancer
13. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome
14. Prostate-specific antigen as a serum marker for adeno-carcinoma of the prostate
15. Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis
16. Chemotherapy for advanced ovarian cancer: Overview of randomized trials
17. Validation of a prediction model and its predictors for the histology of residual masses in non-seminomatous testicular cancer
18. Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma
19. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo